UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4682) 4682
Book Chapter (46) 46
Newsletter (20) 20
Newspaper Article (13) 13
Conference Proceeding (5) 5
Dissertation (3) 3
Magazine Article (3) 3
Book / eBook (2) 2
Paper (1) 1
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
bortezomib (4270) 4270
humans (3949) 3949
science & technology (3678) 3678
life sciences & biomedicine (3492) 3492
oncology (1819) 1819
multiple myeloma - drug therapy (1788) 1788
male (1742) 1742
multiple myeloma (1696) 1696
female (1682) 1682
boronic acids - therapeutic use (1535) 1535
pyrazines - therapeutic use (1527) 1527
hematology (1443) 1443
middle aged (1442) 1442
antineoplastic agents - therapeutic use (1352) 1352
aged (1280) 1280
antineoplastic combined chemotherapy protocols - therapeutic use (1270) 1270
treatment outcome (1020) 1020
adult (943) 943
pyrazines - administration & dosage (927) 927
boronic acids - administration & dosage (926) 926
animals (795) 795
cancer (703) 703
boronic acids - pharmacology (675) 675
pyrazines - pharmacology (672) 672
proteasome inhibitors (661) 661
antineoplastic agents - pharmacology (578) 578
cell line, tumor (575) 575
care and treatment (560) 560
apoptosis (553) 553
dexamethasone - administration & dosage (530) 530
bortezomib - therapeutic use (520) 520
multiple myeloma - pathology (518) 518
thalidomide - analogs & derivatives (514) 514
aged, 80 and over (503) 503
apoptosis - drug effects (496) 496
boronic acids - adverse effects (492) 492
pyrazines - adverse effects (491) 491
chemotherapy (485) 485
mice (449) 449
protease inhibitors - therapeutic use (440) 440
thalidomide - therapeutic use (434) 434
research (431) 431
drug therapy (429) 429
thalidomide - administration & dosage (399) 399
antineoplastic combined chemotherapy protocols - adverse effects (395) 395
dexamethasone (390) 390
proteins (385) 385
hemic and lymphatic diseases (371) 371
transplantation (370) 370
multiple myeloma - therapy (366) 366
prognosis (366) 366
multiple myeloma - mortality (357) 357
recurrence (355) 355
bortezomib - administration & dosage (352) 352
pharmacology & pharmacy (340) 340
medicine & public health (338) 338
analysis (334) 334
thalidomide (333) 333
lenalidomide (331) 331
antineoplastic agents - adverse effects (326) 326
retrospective studies (322) 322
health aspects (309) 309
dexamethasone - therapeutic use (308) 308
patients (302) 302
stem cells (299) 299
proteasome endopeptidase complex - metabolism (289) 289
dosage and administration (288) 288
multiple myeloma - complications (282) 282
hematology, oncology and palliative medicine (281) 281
abridged index medicus (278) 278
drug resistance, neoplasm (273) 273
antineoplastic agents - administration & dosage (268) 268
stem cell transplantation (265) 265
bortezomib - pharmacology (264) 264
cell biology (264) 264
disease-free survival (261) 261
multiple myeloma - diagnosis (257) 257
survival analysis (257) 257
clinical trials as topic (253) 253
tumors (244) 244
transplantation, autologous (243) 243
bone marrow (239) 239
dose-response relationship, drug (238) 238
multiple myeloma - genetics (236) 236
medicine (231) 231
combined modality therapy (230) 230
clinical trials (229) 229
cell proliferation - drug effects (228) 228
drug synergism (219) 219
immunology (218) 218
remission induction (217) 217
hematopoietic stem cell transplantation (214) 214
multiple myeloma - metabolism (210) 210
gene expression (208) 208
proteasome inhibitors - pharmacology (205) 205
proteasome inhibitors - therapeutic use (204) 204
medical research (203) 203
rituximab (201) 201
drug administration schedule (200) 200
antineoplastic combined chemotherapy protocols - administration & dosage (198) 198
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4579) 4579
Japanese (92) 92
Chinese (83) 83
French (35) 35
Czech (19) 19
Spanish (18) 18
German (16) 16
Russian (13) 13
Hungarian (8) 8
Italian (8) 8
Polish (7) 7
Portuguese (6) 6
Danish (2) 2
Norwegian (2) 2
Croatian (1) 1
Dutch (1) 1
Korean (1) 1
Serbian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Paediatric drugs, ISSN 1174-5878, 2010, Volume 12, Issue 2, pp. 85 - 98
Hodgkin lymphoma is one of the few cancers that affect both adults and children. Cure rates for Hodgkin lymphoma remain among the best for pediatric cancers.... 
Anthracyclines, therapeutic use | Chlormethine, therapeutic use | Alkylating-agents, therapeutic use | Brentuximab-vedotin, therapeutic use | Cisplatin, therapeutic use | Bortezomib, therapeutic use | Bleomycin, therapeutic use | Children | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 08/2014, Volume 124, Issue 9, pp. 1404 - 1411
Journal Article
Supportive care in cancer, ISSN 0941-4355, 2/2015, Volume 23, Issue 2, pp. 513 - 524
...Support Care Cancer (2015) 23:513 – 524 DOI 10.1007/s00520-014-2408-8 REVIEW ARTICLE Current use of drugs affecting the central nervous system for chemotherapy... 
Pain Medicine | Anticonvulsants | Chemotherapy | Nursing | Rehabilitation Medicine | Medicine & Public Health | Antidepressants | Oncology | Peripheral neuropathy | Nursing Management/Nursing Research | Cancer | Health Care Sciences & Services | Rehabilitation | Life Sciences & Biomedicine | Science & Technology | Thiophenes - therapeutic use | Peripheral Nervous System Diseases - chemically induced | Humans | Boronic Acids - adverse effects | Antineoplastic Agents - therapeutic use | Pyrazines - therapeutic use | Epothilones - therapeutic use | Boronic Acids - therapeutic use | Epothilones - adverse effects | Taxoids - therapeutic use | Antineoplastic Agents - adverse effects | Taxoids - adverse effects | Thalidomide - adverse effects | Bortezomib | Carbamazepine - analogs & derivatives | Vinca Alkaloids - adverse effects | Anticonvulsants - therapeutic use | Carbamazepine - therapeutic use | Vinca Alkaloids - therapeutic use | Neuralgia - drug therapy | Neoplasms - drug therapy | Antidepressive Agents - therapeutic use | Venlafaxine Hydrochloride | Pyrazines - adverse effects | Central Nervous System - drug effects | Cyclohexanols - therapeutic use | Duloxetine Hydrochloride | Amitriptyline - therapeutic use | Thalidomide - therapeutic use | Peripheral Nervous System Diseases - drug therapy | Drugs | Cancer patients | Care and treatment | Central nervous system | Nervous system | Drug therapy | Neuropathology | Index Medicus
Journal Article
Blood, ISSN 1528-0020, 11/2017, Volume 130, Issue 22, pp. 2392 - 2400
Journal Article
Head & neck, ISSN 1043-3074, 05/2012, Volume 34, Issue 5, pp. 736 - 745
The incidence of thyroid cancer continues to increase and this neoplasia remains the most common endocrine malignancy. No effective systemic treatment... 
epidermal growth factor (EGF) | RET | immunomodulator | vascular disrupting agent | multi‐kinase inhibitor | vascular endothelial growth factor (VEGF) | thyroid cancer | histone acetylation | B‐Raf | heat shock protein (HSP) | multi-kinase inhibitor | B-Raf | Otorhinolaryngology | Life Sciences & Biomedicine | Surgery | Science & Technology | Niacinamide - analogs & derivatives | Anilides - therapeutic use | Bibenzyls - therapeutic use | Humans | Antineoplastic Agents - therapeutic use | Benzenesulfonates - therapeutic use | Pyrazines - therapeutic use | Boronic Acids - therapeutic use | Proto-Oncogene Proteins c-kit - antagonists & inhibitors | Thalidomide - analogs & derivatives | Angiogenesis Inhibitors - therapeutic use | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Receptors, Vascular Endothelial Growth Factor - antagonists & inhibitors | Valproic Acid - therapeutic use | Depsipeptides - therapeutic use | Imidazoles - therapeutic use | Lactams, Macrocyclic - therapeutic use | Pyrroles - therapeutic use | Pyridines - therapeutic use | Bortezomib | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Piperazines - therapeutic use | Imatinib Mesylate | Sulfonamides - therapeutic use | Thyroid Neoplasms - drug therapy | HSP90 Heat-Shock Proteins - antagonists & inhibitors | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Quinazolines - therapeutic use | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Hydroxamic Acids - therapeutic use | Indoles - therapeutic use | Histone Deacetylase Inhibitors - therapeutic use | Quinolines - therapeutic use | Benzamides | Thalidomide - therapeutic use | Benzoquinones - therapeutic use | Indazoles - therapeutic use | Protein-Tyrosine Kinases - antagonists & inhibitors | Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 03/2015, Volume 372, Issue 10, pp. 944 - 953
Journal Article